Gefitinib Impurity 36 | CAS 134187-43-2 - Request Quote
Gefitinib Impurity 36
| SZ CAT No: | SZ-G018056 |
| CAS No | 134187-43-2 |
| Mol.F. | C7H14BrNO : HCl |
| Mol.Wt. | 208.1 : 36.5 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 125422-83-5 (Free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gefitinib Impurity 36 is chemically 4-(3-Bromopropyl)morpholine hydrochloride. Gefitinib Impurity 36 is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity 36 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 134187-43-2
Purchase 134187-43-2
Order 134187-43-2
Enquire 134187-43-2
price of 134187-43-2
134187-43-2 Supplier
134187-43-2 Manufacturer
134187-43-2 Exporter
buy high quality Gefitinib Impurity 36
Purchase Gefitinib Impurity 36
Gefitinib Impurity 36 suppliers
Gefitinib Impurity 36 manufacturers
Gefitinib Impurity 36 price
Order Gefitinib Impurity 36
Enquire Gefitinib Impurity 36
Gefitinib Impurity 36 cost
Gefitinib Impurity 36 Supplier
Gefitinib Impurity 36 Distributor
Gefitinib Impurity 36 for Method Validation
Gefitinib Reference Standard
Gefitinib Impurity 36 for ANDA Filing
Gefitinib Impurity 36 for Forced Degradation Studies
Gefitinib Impurity 36 Identification Standards
Gefitinib Impurity 36 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


